反応式
[F:1][CH:2]([F:34])[O:3][C:4]1[CH:9]=[CH:8][C:7]([NH:10][C:11]2[N:12]=[N:13][C:14](/[CH:17]=[CH:18]/[C:19]3[CH:20]=[C:21]4[C:25](=[CH:26][CH:27]=3)[N:24]([CH:28]3[CH2:33][CH2:32][CH2:31][CH2:30][O:29]3)[N:23]=[CH:22]4)=[CH:15][CH:16]=2)=[CH:6][CH:5]=1>C(OCC)(=O)C.[Pd]>[F:34][CH:2]([F:1])[O:3][C:4]1[CH:9]=[CH:8][C:7]([NH:10][C:11]2[N:12]=[N:13][C:14]([CH2:17][CH2:18][C:19]3[CH:20]=[C:21]4[C:25](=[CH:26][CH:27]=3)[N:24]([CH:28]3[CH2:33][CH2:32][CH2:31][CH2:30][O:29]3)[N:23]=[CH:22]4)=[CH:15][CH:16]=2)=[CH:6][CH:5]=1参加物
4
反応物 1
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of (E)-N-(4-(difluoromethoxy)phenyl)-6-(2-(1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)vinyl)pyridazin-3-amine (0.14 g, 0.302 mmol) in ethyl acetate (5 mL) was added Pd—C (0.064 g, 0.604 mmol and the reaction mixture was stirred at room temperature under H2 for 3 h. The reaction mixture was filtered through pad of celite, washed with ethyl acetate, and the filtrate was concentrated to give N-(4-(difluoromethoxy)phenyl)-6-(2-(1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)ethyl)pyridazin-3-amine as a yellow solid (0.13 g, 80%). LCMS (ES-API), m/z 466.6 (M+H).
後処理
- filtrationThe reaction mixture was filtered through pad of celite
- washwashed with ethyl acetate
- concentrationthe filtrate was concentrated
出典と根拠
- ORDレコード
- ord-fa8a752a6dfa4ae880f336a7d4d20644
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08841301B2
関連ノート
読み込み中…